Metabolic and Kidney Disorders Correlate with High Atazanavir Concentrations in HIV-Infected Patients: Is It Time to Revise Atazanavir Dosages?Cristina Gervasoni, Dario Cattaneo, Paola Meraviglia et al.|PLoS ONE|2015Cited by 28
ContributorsMuzaffar Abbas, Rupesh K. Gautam, Nizar A. Al‐Shar’i et al.|Elsevier eBooks|2021Cited by 0